Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on: August 30,2024

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on:August 30,2024

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Updated on: July 01,2024

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Updated on:July 01,2024

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on: May 29,2024

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on:May 29,2024

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya

Updated on: May 29,2024

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya

Updated on:May 29,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on: June 28,2024

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on:June 28,2024

Diabetes and obesity can cause liver failure—but few people know their risk of developing liver disease

by Madona Azar,The ConversationCredit: Unsplash/CC0 Public DomainLiver disease is frighteningly common worldwide.Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrell

Updated on: August 06,2024

Diabetes and obesity can cause liver failure—but few people know their risk of developing liver disease

by Madona Azar,The ConversationCredit: Unsplash/CC0 Public DomainLiver disease is frighteningly common worldwide.Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrell

Updated on:August 06,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on: July 01,2024

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on:July 01,2024

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on: July 01,2024

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on:July 01,2024

Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?ByJames Myhre & Dennis Sifris, MDPublished on November 17, 2022Medically reviewed byIsabel Casimiro, MD, PhDDiabetes&nbs

Updated on: July 01,2024

Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?ByJames Myhre & Dennis Sifris, MDPublished on November 17, 2022Medically reviewed byIsabel Casimiro, MD, PhDDiabetes&nbs

Updated on:July 01,2024

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on: June 03,2024

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on:June 03,2024

Assessing the mechanisms for liver fibrosis

by First Hospital of Jilin UniversityHepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. Credit: Wajahat MehalChro

Updated on: May 28,2024

Assessing the mechanisms for liver fibrosis

by First Hospital of Jilin UniversityHepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. Credit: Wajahat MehalChro

Updated on:May 28,2024